CBS NewsLean L·
Moderna stock surges as melanoma vaccine trial shows "landmark moment"
Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.
Read at CBS News →
US · 2 sources covering this
Moderna stock surges as melanoma vaccine trial shows "landmark moment"
Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.
Coverage spectrum
2 L · 0 C · 0 R
How 2 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/a7137df9b4756daf1d3c7732cab8d482327c5ac2" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Moderna stock surges as melanoma vaccine trial shows "landmark moment""></iframe>
